Placebo effect and antidepressants: A review enlightened by psychoanalysis

被引:3
|
作者
Keller, Pascal-Henri [1 ,2 ]
Giroux-Gonon, Annie
Gonon, Francois [3 ]
机构
[1] Univ Poitiers, CAPS EA4050, Poitiers, France
[2] Univ Bordeaux, Inst Malad Neurodegenerat, CNRS UMR 5293, F-33076 Bordeaux, France
[3] Univ Bordeaux, Inst Malad Neurodegenerat, CNRS UMR 5293, F-33076 Bordeaux, France
来源
EVOLUTION PSYCHIATRIQUE | 2013年 / 78卷 / 02期
关键词
Placebo; Antidepressant; Depression; Psychoanalysis; Transference; Physician-patient relationship; Medical psychology; Review; RANDOMIZED CONTROLLED-TRIAL; MENTAL-HEALTH-TREATMENT; TERM PSYCHODYNAMIC PSYCHOTHERAPY; COLLABORATIVE RESEARCH-PROGRAM; CLINICAL-TRIALS; NATIONAL-INSTITUTE; PATIENT BELIEFS; SPONTANEOUS IMPROVEMENT; PARKINSONS-DISEASE; NO TREATMENT;
D O I
10.1016/j.evopsy.2013.02.004
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Scientific medicine regards placebo prescription as a lack of treatment, a control condition required to validate new therapies. However, recent studies show that placebo treatments induce beneficial effects that are larger than those observed during spontaneous healing, especially regarding depression, anxiety and other mood disorders. Here we review this literature, including meta-analyses showing that, except for severely depressed patients, placebo treatments are as effective as antidepressants. Then, we review studies concerning the conditions that modulate the size of the placebo effect in depression. We emphasize studies showing that a neurobiological conception of depression, held either by patients or their physicians, impairs healing. These observations call for considering the placebo effect as resulting from an interpersonal relationship that should be interpreted in reference to the psychoanalytical concept of transference. During a placebo treatment, the patient exchanges the medical acknowledgement of his patient status for a temporary improvement of his symptoms, but his transference is not taken into account by his physician. Actually, psychodynamic and cognitive-behavioral psychotherapies induce lasting improvements compared to placebo or antidepressant treatments. According to our interpretation, when psychotherapists take care of patient transference, including its heavy emotive power, their patients become conscious of their unconscious repetitions stemming from childhood and are able to free themselves from them. We conclude by a few suggestions regarding the training of psychotherapists and the excessive medicalization of psychic distress. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:327 / 340
页数:14
相关论文
共 50 条
  • [31] Placebo in the investigation of psychotropic drugs, especially antidepressants
    Puzynski, S
    SCIENCE AND ENGINEERING ETHICS, 2004, 10 (01) : 135 - 142
  • [32] Psychoanalysis Review
    Schottlaender
    PSYCHE-ZEITSCHRIFT FUR PSYCHOANALYSE UND IHRE ANWENDUNGEN, 1948, 2 (01) : 146 - 147
  • [33] Placebo in the investigation of psychotropic drugs, especially antidepressants
    Stanisław Pużyński
    Science and Engineering Ethics, 2004, 10 : 135 - 142
  • [34] The effect of smoking on the plasma concentration of tricyclic antidepressants: a systematic review
    Lundstrom, Nicklas Hasselblad
    Holgersen, Nikolaj K.
    Haastrup, Maija Bruun
    ACTA NEUROPSYCHIATRICA, 2022, 34 (01) : 1 - 9
  • [35] Placebo effect in the treatment with antidepressants: Implications for the scientific evaluation and clinical use of pharmaceutical treatments of depression
    Rief, Winfried
    Kube, Tobias
    NERVENARZT, 2025, 96 (02): : 128 - 137
  • [36] The Placebo Effect in Sports PerformanceA Brief Review
    Christopher J. Beedie
    Abigail J. Foad
    Sports Medicine, 2009, 39 : 313 - 329
  • [37] Book review: The placebo effect: An interdisciplinary exploration
    Harrington, A.
    Nature, 1999, 399 (6735):
  • [38] The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depressionA meta-analysis
    Michael Bauer
    Puvan Tharmanathan
    Hans-Peter Volz
    Hans-Juergen Moeller
    Nick Freemantle
    European Archives of Psychiatry and Clinical Neuroscience, 2009, 259 : 172 - 185
  • [39] Nightmares and antidepressants: a review
    Robles Martinez, M.
    Palma-Alvarez, R. F.
    Garcia-Carretero, M. A.
    Aguelo Rueda, S.
    Rodriguez Gonzalez, C.
    Fonseca, F.
    Torrens, M.
    EUROPEAN PSYCHIATRY, 2019, 56 : S218 - S218
  • [40] Intravenous antidepressants: A review
    Moukaddam, NJ
    Hirschfeld, RMA
    DEPRESSION AND ANXIETY, 2004, 19 (01) : 1 - 9